Royal Arc Electrodes Share Price & Earnings Call Analysis
- Market cap
- ₹167 Cr
- P/E
- 16.57
- ROE
- 13.13%
- PEG
- 16.24
- Price to sales
- 1.43
- Debt to equity
- 0.00
- Sales growth (5Y)
- 21.86%
- EBITDA margin
- 13.30%
- Net profit margin
- 8.66%
- Promoter holding
- 72.96%
- Sales (last year)
- ₹116 Cr
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Industrial Products companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹448 Cr | 17.9 | |
| 2 | 40%+ | Up 2%+ | ₹413 Cr | 12.0 | |
| 3 | 40%+ | Up 2%+ | ₹324 Cr | 22.7 | |
| 4 | 40%+ | Up 0–2% | ₹1,496 Cr | 32.8 | |
| 5 | 40%+ | Up 0–2% | ₹1,079 Cr | 12.7 | |
| 6 | 40%+ | Flat | ₹827 Cr | 21.4 |
Sign up free to see every company in the sector ranking and track Royal Arc Electrodes.
Pro shows every company guiding 40%+ revenue growth →Full Industrial Products rankingFinancials of Royal Arc Electrodes
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Royal Arc Electrodes
Quarterly Results
Quarter-by-quarter operating performance
Financials of Royal Arc Electrodes
Profit & Loss
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 65 | 64 | 64 | 43 | 63 | 97 | 100 | 102 | 116 |
| Expenses + | 59 | 58 | 61 | 40 | 59 | 82 | 83 | 87 | 101 |
| Operating Profit | 6 | 6 | 3 | 3 | 4 | 15 | 17 | 15 | 15 |
| OPM % | 9% | 9% | 5% | 7% | 6% | 15% | 17% | 15% | 13% |
| Other Income + | 0 | 0 | 1 | 2 | 2 | 1 | 1 | 0 | 2 |
| Interest | 3 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 |
| Profit before tax | 2 | 2 | 2 | 2 | 3 | 13 | 16 | 12 | 14 |
| Tax % | 37% | 34% | 23% | 27% | 25% | 27% | 26% | 25% | 26% |
| Net Profit + | 1 | 1 | 1 | 2 | 2 | 10 | 12 | 9 | 10 |
| EPS in Rs | 5.33 | 6.48 | 6.54 | 8.63 | 11.65 | 52.58 | 13.04 | 8.12 | 9.05 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Royal Arc Electrodes
Balance Sheet
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 2 | 9 | 11 | 11 |
| Reserves | 9 | 11 | 15 | 17 | 19 | 29 | 33 | 61 | 70 |
| Borrowings + | 28 | 24 | 12 | 8 | 8 | 1 | 0 | 1 | 0 |
| Other Liabilities + | 13 | 12 | 10 | 12 | 14 | 12 | 10 | 8 | 10 |
| Total Liabilities | 52 | 48 | 39 | 39 | 42 | 44 | 52 | 81 | 91 |
| Fixed Assets + | 21 | 18 | 15 | 16 | 15 | 14 | 18 | 21 | 25 |
| CWIP | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 2 |
| Other Assets + | 30 | 30 | 25 | 24 | 28 | 29 | 33 | 57 | 59 |
| Total Assets | 52 | 48 | 39 | 39 | 42 | 44 | 52 | 81 | 91 |
Financials of Royal Arc Electrodes
Cash Flows
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 7 | 3 | 6 | 7 | 2 | 13 | 6 | 4 | 8 |
| Cash from Investing Activity + | -8 | 2 | 1 | -3 | -1 | -2 | -6 | -7 | -11 |
| Cash from Financing Activity + | -1 | -5 | -8 | -5 | -2 | -7 | -2 | 21 | -1 |
| Net Cash Flow | -2 | 0 | -2 | -0 | -0 | 3 | -2 | 18 | -5 |
| Free Cash Flow | -1 | 2 | 6 | 5 | 1 | 11 | 1 | -4 | -4 |
| CFO/OP | 132% | 51% | 176% | 252% | 77% | 88% | 56% | 49% | 73% |
Financials of Royal Arc Electrodes
Ratios
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56 | 61 | 61 | 90 | 76 | 62 | 75 | 75 | 81 |
| Inventory Days | 104 | 104 | 83 | 102 | 84 | 33 | 50 | 75 | 57 |
| Days Payable | 76 | 69 | 55 | 95 | 79 | 42 | 30 | 25 | 7 |
| Cash Conversion Cycle | 83 | 96 | 90 | 97 | 81 | 53 | 96 | 125 | 132 |
| Working Capital Days | 96 | 103 | 40 | 67 | 51 | 52 | 82 | 106 | 112 |
| ROCE % | 12% | 12% | 14% | 46% | 44% | 22% | 18% |
Continue your research
Others in Industrial Products this season
- Cosmo First (Q2 FY27)
Q2 FY27 Net Revenue: ₹1,388 Cr, +51% YoY (vs ₹919 Cr in Q2 FY26) [Page 10, 3] . Key investor presentation takeaways from Cosmo First Ltd's Q2 FY27 investor pres
- Inox India Ltd (Q2 FY27)
Q2 FY27 revenue: ₹467 Cr, up 26.6% YoY from ₹369 Cr in Q2 FY26 (Page 20). Key investor presentation takeaways from Inox India Ltd's Q2 FY27 investor presentatio
- Subros Ltd (Q2 FY27)
1,198.90 Cr. Key investor presentation takeaways from Subros Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.
- Graphite India (Q2 FY27)
826 Crores, up 13.3% year-on-year (YoY) (Page 4, 9, 14) . Key investor presentation takeaways from Graphite India Ltd's Q2 FY27 investor presentation — and how